Login
Toggle navigation
Videos
Categories
Trending
From combating food waste to pioneering projects|Archie Thomason,Associate,Milltrust International LLP
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
investor passionate about AgTech and the future of food production.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
invests in innovative fintech companies in emerging markets|Monica Brand Engel,Co-founder and Managing Partner,Quona Capital
00:10:00
A Decade-Long Partnership in Sport and Community | Bill Winters, CEO, Standard Chartered.
00:10:00
Dr. K.R. Sridhar, Bloom Energy co-founder, reflects on the journey of bringing Bloom Energy from his garage in Tucson, Arizona, to Silicon Valley.|KR Sridhar,is the PhD Founder, Chairman and Chief Executive Officer of Bloom Energy Corp.
00:00:00
Karin Fischer, CEO, RLS Global
00:10:00
Bloomberg Talks with Ranesh Ramanathan: Banks Forge New Paths into Direct Lending Arena | Ranesh Ramanathan - Partner, akin gump strauss hauer & feld llp
00:10:00
Sector Analysis: Insights into the Energy Sector by Juan Huerta de Soto - Cobas AM
00:10:00
The head of Ignitis Group rang the closing bell, marking the end of the stock exchange trading day, with company representatives present to commemorate the occasion.
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
Eric Pharis Discusses BlackBoxStocks' Tools for Profiting in the Market | Eric Pharis, Founder, BlackBoxStocks Inc.
00:10:00
Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai.
00:10:00
Henry Albrecht and Jack Smith Discuss Innovation at Startup Grind Eastside | Henry Albrecht, CEO , Limeade Inc.
00:10:00
Gives us an update on what he's been busy with and why there hasn't been a new episode for a few weeksDr James R. McIlroy , CEO OF ENTEROBIOTIX